Morinda citrifolia (noni) reduces cancer risk in current smokers by decreasing aromatic DNA adducts

Nutrition and Cancer

Volumn 61, Issue 5, 2009, Pages 634-639

  Wang, Mian Ying ^a   Peng, Lin ^a   Lutfiyya, May Nawal ^a   Henley, Eric ^a   Weidenbacher Hoper, Vicki ^a   Anderson, Gary ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DNA ADDUCT; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORINDA CITRIFOLIA; NUTRITIONAL SUPPORT; SEX DETERMINATION; SUPPLEMENTATION;

ADOLESCENT; ADULT; AGED; ANTICARCINOGENIC AGENTS; BEVERAGES; BIOLOGICAL MARKERS; DNA ADDUCTS; FEMALE; FRUIT; HUMANS; LYMPHOCYTES; MALE; MEDICINE, TRADITIONAL; MIDDLE AGED; MORINDA; POLYCYCLIC HYDROCARBONS, AROMATIC; SEX CHARACTERISTICS; SMOKING; YOUNG ADULT;

MORINDA CITRIFOLIA;

EID: 70449635973     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580902825605     Document Type: Article

References (47)

1. U.S. Department of Health and Human Services: Women and Smoking-A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2001.
2. Oliveira PA, Colaço A, Chaves R, Guedes-Pinto H, De-La-Cruz P LF, et al.: Chemical carcinogenesis. An Acad Bras Cienc 79, 593-616.
3. Randerath E, Miller RH, Dinesh M, Avittis TA, Dunford A, et al.: Covalent DNA damage in tissues of cigarette smokers as determined by 32Ppostlabeling assay. J Natl Cancer Inst 81, 341-347, 1989.
4. Nesnow S, Ross J, Nelson G, Holden K, Erexson G, et al.: Quantitative and temporal relationships between DNA adduct formation in target and surrogate tissues: implications for biomonitoring. Environ Health Perspect 101(3 Suppl), 37-42, 1993.
5. Sepetdjian E, Shihadeh A, and Saliba NA: Measurement of 16 polycyclic aromatic hydrocarbons in narghile waterpipe tobacco smoke. Food Chem Toxicol 46, 1582-1590, 2008.
6. Kriek E, Rojas M, Alexandrov K, and Bartsch H: Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk. Mut Res 1-2, 215-231, 1998.
7. Li D, Wang M, Dhingra K, and Hittleman WN: Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56, 287-293, 1996.
8. Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, et al.: DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res 58, 38-41, 1998.
9. Mooney LA, Santella RM, Covey L, Jeffrey AM, Bigbee W, et al.: Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol Biomarkers Prev 4, 627-634, 1995.
10. Zhang LF, Xu K, and Li XM: Quantitative study on DNA-adduct in normal lung tissues of smoking and non-smoking lung cancer patients. Zhonghua Yu Fang Yi Xue Za Zhi 28, 206-209, 1994.
11. Wiencke JK, ThurstonSW,Kelsey KT, et al.: Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst 91, 614-619, 1999.
12. Schoket B, Kostic S, and Vincze I: Determination of smoking-related DNA adducts in lung-cancer and non-cancer patients. IARC Sci Publ 124, 315-319, 1993.
13. Kriek E, Van Schooten FJ, Hillebrand MJ, Van Leeuwen FE, Den Engelse L, et al.: DNA adducts as a measure of lung cancer risk in humans exposed to polycyclic aromatic hydrocarbons. Environ Health Perspect 99, 71-75, 1993.
14. Wiencke JK, Kelsey KT, Varvony A, et al.: Correlation of DNA adducts in blood mononulear cells with tobacco carcinogen-induced damage in human lung. Cancer Res 55, 4910-4914, 1995.
15. Phillips DH, Hewer A,Martin CN, Garner R, and King MM: Correlation of DNA adduct levels in human lung with cigarette smoking. Nature (Lond) 336, 790-792, 1988.
16. van Schooten FJ, Hillebrand MJ, van Leeuwen FE, et al.: Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis 11, 1677-1681, 1990.
17. Peluso M, Neril M, Margarino, Mereu C, Munnia A, et al.: Comparison of DNA adduct levels in nasal mucosa, lymphocytes and bronchial mucosa of cigarette smokers and interaction with metabolic gene polymorphisms. Carcinogenesis 25, 2459-2465, 2004.
18. Veglia F, Matullo G, and Vineis P: Bulky DNA adducts and risk of cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 12, 157-160, 2003.
19. Hafizur Rahman M, Iqbal Arslan M, Chen Y, Alil S, Parvin T, et al.: Polycyclic aromatic hydrocarbon-DNA adducts among rickshaw drivers in Dhaka City, Bangladesh. Int Arch Occup and Environ Health 76, 533-538, 2003.
20. Hsu TM, Zhang YJ, and Santella RM: Immunoperoxidase quantitation of 4-aminobiphenyl- and polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral and urothelial cells of smokers and nonsmokers. Cancer Epidemiol Biomarkers Prev 6, 193-199, 1997.
21. Castãno-Vinyals G, Talaska G, Rothman N, Alguacil J, Garcia-Closas M, et al.: Bulky DNA adduct formation and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev 16, 2155-2159, 2007.
22. Gyorffy E, Anna L, Gyori Z, et al.: DNA adducts in tumor, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay. Carcinogenesis 25, 1201-1209, 2004.
23. Alexandrov K, Rojas M, and Rolando C: DNA damage by benzo(a)pyrene in human cells is increased by cigarette smoke and decreased by a filter containing rosemary extract, which lowers free radicals. Cancer Res 66, 11938-11945, 2006.
24. Mooney LA, Madsen AM, Tang D, Orjuela MA, Tsai WY, et al.: Antioxidant vitamin supplementation reduces benzo(a)pyrene-DNA adducts and potential cancer risk in female smokers. Cancer Epidemiol Biomarkers Prev 14, 237-242, 2005.
25. Morton J: The ocean-going noni, or Indian mulberry (Morinda citrifolia, Rubiaceae) and some of its "colorful" relatives. Econ Bot 46, 241-257, 1992.
26. Wang MY,West BJ, Jensen CJ, et al. Morinda citrifolia (Noni): a literature review and recent advances in noni research. Acta Pharmacol Sin 23, 1127-1141, 2002.
27. Hiramatsu T: Induction of normal phenotypes in ras-transformed cells by damnacanthal from Morinda citrifolia. Cancer Lett 73, 161-166, 1993.
28. Arpornsuwan T and Punjanon, T: Tumor cell-selective antiproliferative effect of the extract from Morinda citrifolia fruits. Phytother Res 20, 515-517, 2006.
29. Division of Cancer Prevention, NCI Research in Complementary and Alternative Medicine: Developing Effective and Efficient Treatments: Noni Juice Studied for Prevention of Breast Cancer From Dr. Wang, M-Y, UIC College of Medicine at Rockford. NCI Annual Report on Complementary and Alternative Medicine Fiscal Year 2006.
30. Wang MY and Su C: Cancer preventive effect of Morinda citrifolia. Ann NY Acad Sci 952, 161-168, 2002.
31. Wang MY, Peng L, Anderson G, and Nowicki D: Breast cancer preventions with Morinda citrifolia Fruit. Proceedings of the National Cancer Institute; Cancer Researchers and CAM Practitioners: Fostering Collaborations; Advancing the Science. Sponsored by the Office of Cancer Complementary and Alternative Medicine, Bethesda,Maryland, October 21-23, 2007.
32. European Commission: Commission decision of 5 June 2003 authorizing the placing on the market of "Nonie juice" as a novel food ingredient under regulation: (EC) Nr. 258/97 of the European parliament and of the council. Eur J Cancer Prev 12, 144, 2003.
33. MPBiomedicals:Retrieved from http://www.mpbio.com/productinfo.php? productsid=6003500
34. Reddy M and Randerath K: Nuclease P1-mediated enhancement of sensitivity for structurally diverse DNA adducts. Carcinogenesis 7, 1543-1551, 1986.
35. Wang MY and Lu LJW: Differential effect of gestation stage on benzo(a)pyrene-induced micronucleus formation and/or covalent DNA modifications in mice. Cancer Res 50, 2146-2151, 1990.
36. Lu LJW and Wang MY: Modulation of benzo(a)pyrene-induced covalent DNA modification in adult and fetal mouse tissues by gestation stage. Carcinogenesis 11, 1367-1372.
37. Randerath K, Gupta RC, and Randerath E: 3H- and 32P-derivative methods for base composition and sequence analysis of RNA. Methods Enzymol 65, 638-680, 1980.
38. Phillips DH and Arlt VM: The 32P-postlabeling assay for DNA adducts. Nat Protoc 2, 2772-2781, 2007.
39. Brookes ST,Whitley E, Peters TJ, Mulheran PA, EggerM, et al.: Subgroup analyses in randomized controlled trials: quantifying the risks of falsepositives and false-negatives. Health Technol Assess 5, 1-56, 2001.
40. Leandro-Merhi VA, Diez Garcia RW,Monaco DV, and Marques de Oliveira MR: Comparative analysis of nutritional status, food intake, and length of hospitalization considering two hospitals: public versus private. Nutr Hosp 21, 32-37, 2006.
41. Nia AB, Maas LM, Brouwer FMC, Kleinjans JCS, and Van Schooten FJ: Comparison between smoking-related DNA adduct analysis in induced sputum and peripheral blood lymphocytes. Carcinogenesis 21, 1335-1340, 2000.
42. Mucha L, Stephenson J, Morandi N, and Dirani R:Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 3, 279-291, 2006.
43. Weitberg ,A B and Corvese D:Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin Genet 43, 88-91, 1993.
44. De Flora S, Izzotti A, Randerath K, et al. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine. Mutat Res 366, 197-238, 1996.
45. Breast Cancer Family Registry, Kathleen Cuningham Consortium for Research into Familial Breast Cancer (Australasia), and Ontario Cancer Genetics Network (Canada): Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years. Breast Cancer Res Treat 109, 67-75, 2008.
46. Nia AB, Kleinjans JCS, and Van Schooten FJ: Biomonitoring of tobacco smoke carcinogenicity by dosimetry of DNA adducts and genotyping and phenotyping of biotransformational enzymes: a review on polycyclic aromatic hydrocarbons. Biomarkers 7, 209-229, 2002.
47. Firozi PF, Bondy ML, Sahin AA, Chang P, Lukmanji F, et al.: Aromatic DNAadducts and polymorphisms ofCYP1A1,NAT2, andGSTM1in breast cancer. Carcinogenesis 23, 301-306, 2002.